News, Press Releases & Press Articles

Please find below news and press releases issued by Alba Biosciences and the Quotient group of companies:

 1 2 3 >  Last ›

Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led By Paul Cowan and Galen Partners

Date: 01/03/2013

Edinburgh, Scotland and Newtown, PA, U.S.A, February 25, 2013 -- Quotient Biodiagnostics (“Quotient”), a global transfusion diagnostics group, is pleased to announce that its... Read More


FDA Approval for Rare Polyclonal Antisera Products

Date: 05/10/2012

Scottish Based Global Diagnostic Company receives FDA License to Sell a Range of Rare Polyclonal Antisera Products in the USAEdinburgh, United Kingdom, October 5th, 2012 - Alba Bioscience Limited... Read More


Quotient Biodiagnostics Raises $11.2 Million of Growth Finance

Date: 09/03/2012

Quotient Biodiagnostics Raises $11.2 Million of Growth Finance Led by Galen Partners   Edinburgh, Scotland and Newtown, PA, U.S.A, March 5, 2012 /PR Newswire/ -- Quotient Biodiagnostics... Read More


FDA Approval for Reagent Red Cells

Date: 23/01/2012

  Scottish Diagnostics Company Receives FDA License to Sell An Additional Range of Transfusion Diagnostic Products in the USA   Edinburgh, United Kingdom, January 19th, 2012 / -- Alba... Read More


England & Wales Direct

Date: 28/07/2010

Alba Bioscience announced that it is directly entering the English and Welsh markets.Alba Bioscience has, since early 2000, distributed in England & Wales via Alpha Labs however in order to... Read More


Alba Bioscience with new business advisor in Latin America

Date: 25/05/2010

Alba Bioscience Biotechnology British company, which manufactures a broad portfolio of products in the area inmohematología, has reached an important agreement with Mr. Guido Véliz to... Read More